Zobrazeno 1 - 10
of 62
pro vyhledávání: '"G Kinra"'
Publikováno v:
Value in Health. 18(7)
Publikováno v:
Value in Health. 18(3)
Publikováno v:
Value in Health. 18(7):A750-A751
Publikováno v:
Indian journal of physiology and pharmacology. 43(2)
Several polypeptide growth factors regulate epithelial and stromal development in endometrium under the influence of estrogen and progesterone, and thereby regulate growth and differentiation of endometrium during menstrual cycle. However, little is
Publikováno v:
Indian journal of cancer. 35(1)
The present study was carried out in 18 patients with carcinoma cervix stage IB through early IIB-Preoperative computerised tomography (C.T.) was done within seven days before surgery. Volume of tumour was determined from the C. T. films. Radical hys
Publikováno v:
Indian journal of pathologymicrobiology. 41(3)
Nucleolar organiser regions (NOR) are chromosomal segments coding for ribosomal RNA. The number of nucleolar organiser regions correlates with cellular proliferation and has a diagnostic and prognostic value in neoplastic diseases. The aim of this st
Publikováno v:
The National medical journal of India. 9(1)
Cancer of the ovary is the second commonest gynaecological malignancy after cancer of the cervix. Surgery followed by cisplatin-based chemotherapy is the standard treatment approach. In patients with persistent disease, second-look laparotomy offers
Publikováno v:
Contraception. 17:103-113
The effect of a single implant-D containing 40 mg of norethindrone acetate on the endometrium and serum progesterone, and its mode of contraceptive action was investigated. 20 women aged 20-40 (parity 1-5) had used implant-D for periods of 7-27 month
Publikováno v:
Contraception. 25:175-184
Sulprostone was given intramuscularly in two dose schedules of 0.5 mg at 4 hourly intervals for 8 doses and 1.0 mg at 8-hour intervals for 4 doses to 56 women in the 12th–20th week of gestation coming for termination of pregnancy. Forty-nine of the
Publikováno v:
Contraception. 16:243-255
Experience with the use of prostaglandin F 2 α (PGF 2 α) and its methyl analogue for the termination of pregnancy associated with medical complications, prior laparotomy and uterine scars or tumours and abnormal pregnancies in 50 patients is presen